Integral Derivatives’s Stryker SYK Stock Holding History

Integral Derivatives’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,200	Closed	-$1.22M	–	1354
2016 Q4	$1.22M	Buy	+10,200	New	+$1.17M	0.02%	453
2015 Q1	–	Sell	-20,000	Closed	-$1.89M	–	1362
2014 Q4	$1.89M	Hold	20,000	–	–	0.03%	456
2014 Q3	$1.61M	Buy	20,000 +15,300	+326%	+$1.26M	0.03%	548
2014 Q2	$396K	Buy	+4,700	New	+$384K	0.01%	1007

Other funds holding SYK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Integral Derivatives's SYK Position: Q1 2015 in Review

Integral Derivatives sold out of Stryker (SYK) in Q1 2015, closing a stake of 2,271 shares — an estimated $214K sold.

Integral Derivatives first reported a position in SYK in Q1 2014 and held it in 4 quarters. The position peaked at $1.21M in Q3 2014. 895 funds tracked by Wall St. Rank hold SYK as of Q1 2015.

Integral Derivatives reported no remaining Stryker position as of Q1 2015 after selling out during the quarter.
Integral Derivatives sold 2,271 Stryker shares in Q1 2015, an estimated $214K.
Integral Derivatives first reported a position in Stryker in Q1 2014 and held it in 4 quarters.
Integral Derivatives's Stryker position peaked at $1.21M in Q3 2014.
895 funds tracked by Wall St. Rank held Stryker as of Q1 2015.

Based on Integral Derivatives's 13F filing for Q1 2015, filed 20 Apr 2015.